MedPath

The effect of vitamin D supplement on treatment and prevention of Coronary Heart Disease

Phase 3
Conditions
Coronary Heart Disease.
Atherosclerotic cardiovascular disease, so described
Registration Number
IRCT201612122365N14
Lead Sponsor
Iran University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Age 30 to 60 years; women and men with coronary heart disease ; Willingness to participate in research
exclusion criteria: BMI >35 kg / m2; Vitamin D levels higher than 30 ng / ml; Disease (cancer, myocardial infarction, diabetes, liver problems and kidney); Drugs using out of treatment protocol; Using oral and injectable nutritional supplements for at least the last 4 months (vitamins D, C, E, calcium, magnesium, potassium and multivitamins, omega-3); Using any herbal remedies; Consumption any foods fortified with vitamin D; pregnancy and lactation; Smoking; Alcohol consumption
withdraw criteria: Consume less than 7 tablets of 8 tablet at the end of the study ; The occurrence of any event that may affect the health; Any acute illness during the study; Unwillingness to continue cooperation in research

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Heat Shock Protein 60. Timepoint: before and 2 month after intervention. Method of measurement: ng/ml by ELISA.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath